Coronary artery spasm : role in acute myocardial ischaemia by Xuereb, Robert G. & Xuereb, Mariosa
Maltese Medical Journal 28 Volume IV Issue I 1992 
CORONARY ARTERY SPASM: 

ROLE IN ACUTE 

MYOCARDIAL ISCHAEMIA 

ROBERT G. XUEREB MD., MR.C'p. (UK) 

MARIOSAXUEREB MD., MR.C.P. (UK) 

DEPARTMENT OF CARDIOLOGY 

ISTITUTO SCIENTIFICO H SAN RAFFAELE, MILAN, ITALY. 

Addressti)r correspondence: Robert G. Xuereb MD, MRCP (UK), Department ojCardi%gy, 

Istituto Scientifico H San Raffaele, Via Olgettina 60, 20132, Milano, Italr. 

INTRODUCTION 
Coronary artery spasm is an accepted 
cause oftransient myocardial ischaemia 
in patients with variant angina. Guazzi 
et all and Maseri et aF have clearly 
demonstrated that in these patients an­
gina is not preceeded by increased 
myocardial metabolic demand. The 
electrocardiographic abnormality, ST 
segment elevation, which is a hallmark 
of this syndrome, resembles that seen 
experimentally when the animal coro­
nary artery is ligated and clinically, 
when the human coronary artery is 
totally occluded by a balloon 
angioplasty catheter. Chierchia et aP 
assessed continuous coronary sinus 
oxygen content and showed a decrease 
in coronary sinus oxygen preceding 
both electrocardiographic changes and 
chest pain, providing the first demon­
stration that a primary reduction in 
blood supply is indeed responsible for 
ischaemia in these patients. 
More recently. coronary artery spasm 
has also been suggested to play an 
important role in the pathophysiology 
of myocardial ischaemia throughout 
the wide clinical spectrum of coronary 
artery disease including effort angina, 
unstable angina, acute myocardial 
infarction and sudden death.4 
DEFINITION 
Coronary artery spasm is defined as a 
severe localized constriction suffi­
ciently profound to cause transient to­
tal or sub-total occlusion ofan epicardial 
coronary artery resu Iling in myocardial 
ischaemia. Dynamic lumen obstruc­
tion is often observed in the proximal 
trunk or trunks, and the right coronary 
artery is most often involved. In some 
cases, spasm may be multifocal or dif­
fuse. It may occur in angiographically 
normal coronary arteries but is usually 
associated with a localized atheroma 
(often subtle) or endothelial disruption 
or dysfunction. 
CHANGING FASHIONS 
Originally, coronary artery spasm was 
considered the main mechanism of 
angina pectoris. Following the recog­
nition of fixed atherosclerotic narrow­
ing in association with angina, this 
concept fell into di srepute. Wilson and 
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10hnston5 reproposed the hypothesis 
of coronary artery spasm in 1941 when 
they described the occurrence of tran­
sient ST segment elevation during an 
episode of chest discomfort in a patient 
whilst smoking a cigarette. The entire 
syndrome of variant angina, an unu­
sual form of angina that occurs exclu­
sively at rest, was described by 
Prinzmetal et al6 in 1959. Following 
these original descriptions, the term 
coronary artery spasm passed through 
another unpopular phase in the early 
1970's until it became a "proven hy­
pothesis".7 The last few years have 
seen a revival in the interest in coro­
nary artery spasm with the publication 
of numerous important papers on its 
pathogenesis. 
PATHOGENESIS: 

AN EVOLVING PICTURE 

No single cause for coronary artery 
spasm has been found. Basic as well as 
clinical investigations indicate that the 
disorder may be the result of multiple 
pathophysiological mechanisms. 
GENETIC FACTORS 
There have been few reports pertaining 
to genetic factors in coronary artery 
spasm. Numano et al8 found a signifi­
cantly low frequency of human leuco­
cyte antigen DQw3 as well as a high 
frequency of Bw52 in 45 Japanese pa­
tients with variant angina as compared 
with 152 normalJ apanese adults. These 
data suggest that some genetic faetor or 
factors may contribute to the 
pathogenesis ofcoronary artery spasm. 
AUTONOMIC NERVOUS SYSTEM 
Sympathetic nervous system: Follow­
ing the demonstration that stimulation 
of alpha-adrenergic receptors with 
epinephrine can cause spasm,9 altered 
adrenergic activity has been suggested 
to play a role in variant angina. How­
ever, Chierchia et al lO analysed the 
Holter electrocardiogram in 8 patients 
with variant angina and failed to reveal 
any increase in heart rate and corrected 
QT interval (both indices of cardiac 
sympathetic activation) in t\:le period 
preceeding the onset of ST segment 
changes. They also showed that the 
frequency of ischaemic episodes was 
not altered by the infusion of the non­
selective alpha-blocker phentolamine. 
Also, specific alphal-receptor block­
ade by prazosin exerted no obvious 
beneficial effects. 1 1 These observa­
tions suggest an insignificant role for 
adrenergic activation in the precipita­
tion of coronary artery spasm. 
Parasympathetic nervous system: A 
number of studies have demonstrated 
that intracoronary infusion of the 
parasympathetic neurotransmitter ace­
tylcholine in patients with variant an­
gina provokes spasm. In one such 
study, Yasue et al 12 induced spasm in 
25 out of 28 patients. However, these 
studies have to be interpreted with cau­
tion as the pharmacological doses of 
intracoronary acetylcholine used do not 
represent the normal physiological con­
dition of parasympathetic stimulation. 
Furthermore, following the observa­
tion that coronary artery spasm can 
also occur in the denervated trans­
planted human heart, I , a primary neu­
ral origin seems unlikely. 
ROLE OF PLATELETS 
Aggregation of platelets results in the 
release ofseveral vasoacti ve substances 
including thromboxane A2 and 
serotonin. 
Thromboxane A2 - Prostacyclin imbal­
ance: Chierchia et al 14 showed that 
inhibition of the potent vasoconstrictor 
thromboxane A2 by the administration 
of a single intravenous low dose of 
aspirin (2mg/kg) had no obvious clini­
cal effect and the frequency, 
severity and duration of 
electrocardiographically documented 
ischaemic episodes remained practi­
cally unchanged. Although the simul­
taneous suppression of coronary 
prostacyclin (PGI2) synthesis might 
have contributed to these largely nega­
tivefindings, this possibility was shown 
to be unlikely by Chierchia et al 15 in a 
study using intravenous infusion of 
antiaggregatory and vasodilator doses 
of synthetic POI2, where coronary 
vasospasm was not prevented in 8 of9 
patients with variant angina. 
Serotonin: Recently there has been 
increasing interest in the role of 
serotonin. McFadden et al 16 induced 
occlusive coronary artery spasm by 
serotonin in 5 patients with variant 
angina at a dose that dilates normal 
vessels. This effect is not prevented by 
intravenou s ketanserin, a 5 -HT2 
receptor blocker. 17 
EFFECT OF HISTAMINE 
A recent post-mortem study18 of a pa­
tient with variant angina suffering sud­
den death demonstrated a significant 
increase in the number of mast cells in 
the coronary artery adventitia. It was 
suggested that histamine or other 
vasoactive substances are important 
mediators in the genesis of spasm. 
Okumara et induced coronaryal 19 
spasm by intracoronary injection of 
histamine through stimulation of HI 
receptors. 
ENDOTHELIAL DYSFUNCTION 
Since Furchgott's2o discovery of an 
endothelium-derived relaxing factor 
(EDRF), later shown to be probably 
nitric oxide, the endothelium has been 
shown to play a pivotal role in the 
control of coronary arterial tone of 
epicardial and resistive vessels. EDRF 
promotes underlying smooth muscle 
relaxation and vasodilation in response 
to various agonists, such as acetylcho­
line, histamine and serotonin, that 
would cause smooth muscle contrac­
tion and vasoconstriction when in di­
rectcontact with smooth muscle. Ithas 
been suggested that disrupted or dys­
functional endothelium, as well as 
atherosclerosis, may prevent coronary 
vasodilation mediated by EDRF, and 
may be important in the genesis of 
coronary artery spasm. However, we 
have recently shown that atheroma and 
acute intimal injury induced by 
percutaneous transluminal coronary 
angioplasty do not influence the 
endothelial-dependent vasodilation in­
duced by low dose intracoronary ace­
tylcholine, 01 suggesting that an altera­
tion of the local endothelial lining is 
unlikely to be the primary cause of 
coronary artery spasm. 
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LOC\UZED SMOOTH MUSCLE 
I j IPERREACTlVITY 
A recent hypothesis proposed for the 
genesis of coronary artery spasm is the 
presence of a hyperreactive coronary 
smooth muscle segment.22 The nature 
of the local coronary alteration that 
makes a particular coronary segment 
hyperreactive to constrictor stimuli is 
not known. 
EFFECT OF COCAINE 
Cocaine users frequently develop si­
lent myocardial ischaemia, especially 
during withdrawal, which is probably 
caused by cocaine-induced coronary 
spasm mediated by alpha-adrenergic 
stimulation. Nademanee et aF3 studied 
21 consecutive long-term male cocaine 
users. 38% had frequent episodes of 
ST elevation on 24-hour ambulatory 
electrocardiographic monitoring. 
From the above studies it can be con­
cluded that a large number of different 
stimuli, and not a specific stimulus 
only, can provoke coronary artery 
spasm. Kaski et aF2 showed that dur­
ing spontaneous spasm in six patients 
with variant angina, the spastic seg­
ments had an average reduction in 
luminal calibre of 64%, whereas all 
unrelated vessels examined contricted 
by an average of only 12%. Thus 
spontaneous local coronary spasm is 
likely to result from a local exagger­
ated coronary contrictor response to a 
variety of stimuli acting on different 
receptors that produce only mild con­
striction in other coronary segments 
and which may be different in different 
patients and even in the same patient at 
different times. 
CLINICAL 

MANIFESTATIONS 

The symptoms of patients with coro­
nary artery spasm depend upon the 
underlying ischaemic clinical syn­
drome. Classically, they present with 
recurrent rest pain associated with re­
versible ST segment elevation and pres­
ervation of exercise capacity. This 
syndrome is termed Prinzmetal's or 
variant angina. The pain is usally more 
severe and of longer duration than that 
observed in effort angina. Attacks tend 
to be clustered between midnight and 6 
a.m., awakening the patient in the very 
early morning at nearly the same time. 
This is important both diagnostically 
and in the planning of drug therapy 
since adequate cover is needed particu­
larly during these critical hours. Spon­
taneous remissions and exacerbations 
are typical of the syndrome. Up to 90% 
of ischaemic episodes caused by coro­
nary artery spasm are silent. Patients 
with Prinzmetal's angina tend to be 
younger than those with classic stable 
effort-induced angina. The male pre­
ponderance is also less evident. Epi­
sodes of spasm may be precipitated by 
emotional stress and smoking. 
Coronary artery spasm may also play a 
role in patients with effort angina who 
exhibit a highly variable threshold for 
the induction of ischaemia, experience 
walk-through angina, demonstrate ST 
segment elevation associated with ef­
fort or an excellent response to calcium 
channel blockers and a poor response 
to beta-blockers. 
Unstable angina results from an abrupt 
alteration in blood supply caused by a 
complex interaction of plaque fissur­
ing, thrombosis and spasm. Coronary 
artery spasm is especially likely in those 
patients who demonstrate ST segment 
elevation during episodes ofchest pain 
and an absence of increase in the indi­
ces ofmyocardial oxygen demand prior 
to the onset of pain. 
Although a relatively rare complica­
tion of variant angina,4 acute myocardial 
infarction has been shown to occur in 
the area supplied by vessels which un­
dergo spasm during transient iscaemic 
epidodes.24 Hackett et aps demonstrated 
that intracoronary nitrates during the 
early phase of acute myocardial 
infarction reverse the intern1ittent coro­
nary occlusion which is frequently ob­
served during coronary angiography 
despite thrombolytic therapy. 
Following the relief oftemporary coro­
nary occlusion due to spasm, life-threat­
ening reperfusion arrhythmias may 
occur. These may present with 
lightheadedness, palpitations, syncope 
or sudden death. 
RECOGNITION OF 

CORONARY ARTERY 

SPASM 

Electrocardiogram 
Although transient ST segment eleva­
tion is the hallmark of coronary artery 
spasm, other ischaemic-type ECG 
changes may occur. These include ST 
segment depression, T wave inversion, 
T wave peaking, pseudonormalization 
ofthe T wave, inversion ofU waves, as 
well as transient appearance of abnor­
mal Q waves. the changes may occur 
in any lead but are more common in the 
inferior leads reflecting the higher fre­
quency of spasm occurring in the right 
coronary artery. Rhythm disturbances 
including AV block and ventricular 
tachycardia may be the only manifesta­
tions. Twenty-four hour ECG Holter 
monitoring is useful for the documen­
tation of both symptomatic and silent 
ischaemic episodes (Figure I) as well 
as for the assessment of the efficacy of 
drug treatment. 
Exercise Stress Testing 
The sensitivity for detecting spasm in 
patients with variant angina by exer­
cise testing is quite low. ST segment 
elevation is observed in 30% of pa­
tients, ST depression in 30% and no 
changes in 40%. However the finding 
of ST elevation is specific for coronary 
artery spasm only when a previous 
myocardial infarction has been ruled 
out. 
Echocardiography 
New transient segmental wall motion 
abnormalities may be observed during 
spontaneous or provoked spasm. 
Myocardial Perfusion Scintigraphy 
Thallium-20 I scintigraphic studies 
performed during attacks of coronary 
artery spasm demonstrate regional 
transmural myocardial perfusion de­
fects corresponding well with leads 
involved by ST segment elevation. 
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Figure 1. High resolution ST trend 
during 24-hour ECG monitoring in a :1 .iiI~~w~~~~r
-5 . .,patient with varient angina showing 
+5 n-".,.! , -s •numerous episodes of transient ST seg­
ment elevation without 
precedingincrease in heart rate. 
Heart rate 
2a 
2h 
Figure 2. Right coronary angiogram 
showing the presence of a duplicate 
posterior descending coronary artery. 
Ca) Spontaneous spasm at origin of 
both branches. Cb) Spasm was relieved 
following intracoronary nitroglycerin. 
Maltese Medical Journal 34 Volume IV Issue I 1992 
40 j 
>­~ 
~ 20 J~ ea I: o o 0 ... o1:.2! 
.- Q) 
Q) E 
Cl ea ~ I: .­
eaOO 
.c 
o -20 -I 
Q) 
Cl 
ea 
1: 
Q) 
o Qj 
0. -40 I 
-60 -"-l - --, 
1 
5 mcg ACh 10 mcg ACh 
Figure 4. Basal electrocardiogram (a) 
and electrocardiogram recorded dur­
ing hyperventilation testing (b) show­
ing pronounced ST segment elevation 
in the anterolateral leads in a 53 year 
old male patient with documented 
Figure 3. Percentage change in proxi­
mal left anterior descending coronary 
artery diameter in a patient with variant 
angina and angiographically normal 
coronary arteries. Intracoronary ace­
tylcholine (ACh) at a low dose of 30 
micrograms causes a marked reduction 
in lumen calibre of 55%. This is re­
1 lieved by intracoronary nitroglycerin 
30 mcg ACh NTG (NTG). 
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spasm of the proximal left anterior de­

scending coronary artery. b) Electrocardiogram after hyperventilation 
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Cardiac catheterization 
Once suspected, a definite diagnosis of 
coronary artery spasm should be made 
during coronary angiography after care­
ful withdrawal of therapy. Visualiza­
tion of spasm causing coronary ob­
struction with resolution following 
intracoronary nitroglycerin is the gold 
standard for diagnosis (Figure 2). The 
location and degree of spasm, the 
number of vessels involved and the 
relationship to underlying fixed stenosis 
are defined. This is important to pro­
vide baseline information for later 
evaluation of therapy and disease ac­
tivity. Ifa spontaneous ischaemic epi­
sode fails to occur during cardiac cath­
eterization, provocative testing should 
be performed. 
Provocative Testing 
Provocative testing is useful in those 
patients whose clinical manifestations 
are suggestive of the presence of coro­
nary artery spasm, especially if normal 
or near normal coronary arteriograms 
are present. As it carries a 4.5% risk of 
arrhythmias in patients with provoked 
spasm, such testing should be carried 
out in the catheterization laboratory. 
This permits the documentation of 
changes in coronary artery diameter 
and allows the immediate use of 
intracoronary nitroglycerin if neces­
sary. Provocative testing is absolutely 
contraindicated in the presence of se­
vere hypertension, severe left ventricu­
lar dysfunction, severe aortic stenosis 
and significant left main stem disease. 
Ergonovine Test . This highly sensitive 
and specific test is the most widely 
used for the provocation of coronary 
artery spasm. Ergonovine, an ergot 
alkaloid, stimulates both alpha­
adrenergic and serotonergic receptors 
and therefore exerts a direct constric­
tive effect on vascular smooth muscle. 
Ergonovine produces chest pain with 
ST segment elevation in the vast ma­
jority of patients with variant angina 
who are in the active phase of the 
disease. Spasm is reversed by prompt 
intracoronary nitroglycerin. 
Acetylcholine. A recent study by 
Okumara et a]26 has shown that 
intracoronary acety lcholine is 90% sen­
sitive and 99% specific for the provo­
cation of spasm in patients with variant 
angina (Figure 3). The advantage of 
this agent is that the response is very 
transient and reverses spontaneously 
within 20 to 30 seconds. However the 
procedure requires temporary right 
ventricular pacing as bradyarrhythmias 
may occur especially with injection of 
acetylcholine in the right coronary ar­
tery. 
Hyperventilation. The effect of sys­
temic alkalosis in provoking coronary 
artery spasm is well documented (Fig­
ure 4). Hyperventilation is less sensi­
tive than ergonovine in the induction of 
spasm but is less risky and may be used 
to provoke milder degrees of spasm. 
TREATMENT 
The medical therapy for coronary ar­
tery spasm is still relatively nonspe­
cific as the mechanisms that lead to 
spasm are still not fully understood. 
The effect rather than the cause is 
treated. The calcium antagonists, ei­
ther alone or in combination with long­
acting nitrates, are the cornerstones of 
treatment. 
MANAGEMENT OF 

THE ACUTE PHASE 

Spasm-related ischaemia is treated with 
sublingual nitroglycerin. If this fails to 
control the anginal episode, intrave­
nous nitroglycerin is given. The dose 
should be titrated in order to achieve 
resolution of symptoms and re-estab­
lishment ofthe basal electrocardiogram. 
Care should be taken to avoid hypoten­
sion and tachycardia as these may 
worsen ischaemia. Coronary spasm is 
usually very sensitive to nitrates, which 
act directly on the vascular smooth 
muscle leading to coronary vasodilation 
in a manner similar to EDRF. In the 
rare instances when spasm proves to be 
refractory to nitrates, a calcium an­
tagonist may be added intravenously. 
The choice of the calcium blocker 
should be made depending on the pres­
ence or absence of bradyarrhythmias 
and left ventricular dysfunction. 
PREVENTION OF 

RECURRENCES 

Intravenous nitrate therapy should be 
continued for some time after the pa­
tient has become symptom-free, keep­
ing in mind the problem of tolerance 
and concurrently starting oral calcium 
antagonist therapy. Verapamil, 
nifedipine, diltiazem and the new 
dihydropyridines nicardi pine and 
nisoldipine have all been demonstrated 
to be clinically efficacious. The dose 
should be tailored according to the in­
dividual patient. During flares of 
ischaemia, the dose should be increased 
to the maximum tolerated. Since dif­
ferent calcium channel blockers have a 
different mechanism on intracellular 
calcium movement, it seems warranted 
to try another agent if one calcium 
channel blocker does not induce a sat­
isfactory clinical response at an appro­
priate dosage. Simultaneous adminis­
tration of two antagonists may be re­
quired in some patients who remain 
symptomatic despite maximum toler­
ated doses of a single drugY 
ASSESSING DRUG 

RESPONSIVENESS 

Both initial and long-term therapies 
should be individualized according to 
duration and seriousness of the symp­
toms, markers of the disease activity, 
angiographic assessment of each pa­
tient and incidence of side effects. The 
most widely used method for evaluat­
ing the efficacy of therapy is ambula­
tory ECG monitoring. Some centres 
also use repeat catheterization and 
ergonovine provocative tests. When 
the patient has been symptom-free and 
with no objective evidence of spasm 
for 1 year, therapy may be withdrawn. 
In view of the possi ble occurrence of a 
rebound phenomenon on withdrawal 
of the calcium antagonists, a tapered 
withdrawal is advocated. 2s Since coro­
nary artery spasm is a potentially life­
threatening disease, the decision to 
withdraw therapy should not be made 
casually. 
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General measures. Factors which pro­
voke spasm,larticularly smoking, cold 
exposure and emotional stress, should 
be avoided. 
Beta-hlockers. Beta-blockade can theo­
retically worsen coronary spasm in 
patients with variant angina through 
blockade of coronary beta-receptors 
accompanied by unopposed alpha­
receptor activity.29 
Aspirin. Aspirin in high doses may 
actually increase the severity of 
ischaemia in Prinzmetal's angina by 
inhibition of the synthesis of 
prostacyclin.10 
Revascularization procedures. 
Revascularization procedures are not 
indicated in patients with coronary ar­
tery spasm and normal coronary arter­
ies. Coronary artery bypass grafting 
may be of some benefit in patients with 
recurrent spasm superimposed on se­
vere atherosclerotic lesions. However, 
because of the possible occurrence of 
diffuse spasm, the results of surgery for 
this condition are not as good as the 
results in patients with angina and no 
evidence of spasm. If surgery is per­
formed, coronary vasodilator therapy 
should be continued post-operatively. 
Similarly, percutaneous transluminal 
coronary angioplasty (P'TCA) may be 
useful in a subgroup of patients with 
spasm on a haemodynamically impor­
tant fixed atherosclerotic lesion, care 
being taken to avoid spasm during and 
after the procedure. 
NATURAL HISTORY 

AND PROGNOSIS 

The natural history of coronary artery 
spasm remains largely speculative be­
cause treatment alters its outcome. It 
however appears to go through an acute 
active phase characterized by frequent 
episodes of angina with eventual re­
mission of both symptomatic and 
asymptomatic ischaemia. Myocardial 
infarction and cardiac events are more 
likely to occur shortly after the initial 
presentation and in those patients in 
OTHER TREATMENT 

MODALlTIES 

whom spasm is superimposed on se­
vere organic coronary lesions. 3 ) Dur­
ing the first six months, non-fatal 
myocardial infarction occurs in up to 
20% of patients and death in up to 10%. 
Patients with coronary artery spasm 
and normal coronary arteries have a 
5% risk for events, whereas those with 
severe multivessel disease have a 30% 
risk. Patients with arrhythmias during 
angina are also at a higher risk for 
sudden death. 
CONCLUSION 
Careful history taking , continuous 
electrocardiographic monitoring and 
exercise stress testing remain the most 
practical means for diagnosing acute 
transient myocardial ischaemia. 
Patients presenting with angina at rest, 
or effort angina with a variable thresh­
old, are likely to have underlying coro­
nary artery spasm. In such patients, an 
electrocardiogram taken during an epi­
sode ofrest pain may clinch the di agno­
sis. These patients should be further 
investigated with coronary 
arteriography combined, if necessary, 
with provocative testing. Nitrates and 
calcium channel blockers appear at 
present to be the most effective drugs in 
the treatment of coronary artery spasm. 
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